Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for Ikena Oncology, Inc. [IKNA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated31 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

-1.12% $ 1.770

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs...

Stats
Today's Volume 492 082
Average Volume 343 706
Market Cap 85.42M
EPS $0 ( 2024-05-20 )
Next earnings date ( $-0.300 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.130
ATR14 $0.00500 (0.28%)
Insider Trading
Date Person Action Amount type
2024-03-01 Germa Caroline Buy 579 100 Stock Option (Right to Buy)
2024-02-29 Germa Caroline Buy 0
2024-02-01 Ecsedy Jeffrey Buy 100 000 Stock Option (Right to Buy)
2024-02-01 Marango Jotin Buy 181 000 Stock Option (Right to Buy)
2024-02-01 Manfredi Mark Buy 320 000 Stock Option (Right to Buy)
INSIDER POWER
97.52
Last 94 transactions
Buy: 20 809 745 | Sell: 873 348

Volume Correlation

Long: 0.20 (neutral)
Short: -0.79 (moderate negative)
Signal:(64.528) Neutral

Ikena Oncology, Inc. Correlation

10 Most Positive Correlations
ALTM0.906
UXIN0.904
AEHR0.903
RNAZ0.897
FDBC0.896
ASTS0.891
AXDX0.886
PLL0.881
BKYI0.881
EVOK0.879
10 Most Negative Correlations
SFBC-0.913
FFNW-0.895
BLPH-0.865
ADTH-0.836
CLST-0.832
KRUS-0.826
OXLCP-0.812
ISRG-0.808
FLXS-0.806
EDUC-0.805

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ikena Oncology, Inc. Correlation - Currency/Commodity

The country flag 0.44
( neutral )
The country flag 0.39
( neutral )
The country flag 0.00
( neutral )
The country flag 0.15
( neutral )
The country flag -0.09
( neutral )
The country flag -0.03
( neutral )

Ikena Oncology, Inc. Financials

Annual 2023
Revenue: $9.16M
Gross Profit: $8.14M (88.86 %)
EPS: $-1.630
FY 2023
Revenue: $9.16M
Gross Profit: $8.14M (88.86 %)
EPS: $-1.630
FY 2022
Revenue: $15.62M
Gross Profit: $13.58M (86.98 %)
EPS: $-1.840
FY 2021
Revenue: $30.99M
Gross Profit: $0.00 (0.00 %)
EPS: $-0.951

Financial Reports:

No articles found.

Ikena Oncology, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ikena Oncology, Inc.

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.8151969909668 seconds
Number of API calls: 2
Number of DB calls: 8